Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,566,444 papers from all fields of science
Search
Sign In
Create Free Account
Oxypurinol
Known as:
DHPP
, 1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol
, Oxipurinolum
Expand
A xanthine oxidase inhibitor.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Broader (1)
Enzyme Inhibitors
In Blood
Oxipurinol:MCnc:Pt:Ser/Plas:Qn
Oxipurinol:SCnc:Pt:Ser/Plas:Qn
agonists
Expand
Narrower (3)
oxithiopurinol
oxypurinol 7-riboside
oxypurinol ribosyl phosphate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromarone
J. Colin
,
R. Farinotti
,
+4 authors
F. Dietlin
European Journal of Clinical Pharmacology
2004
Corpus ID: 21246287
SummaryPrevious studies have described a pharmacokinetic interaction between probenecid, a uricosuric drug, and oxipurinol, the…
Expand
1989
1989
EXAFS analysis of xanthine oxidase complexes with alloxanthine, violapterin, and 6-pteridylaldehyde
R. Hille
,
G. George
,
M. K. Eidsness
,
S. Cramer
1989
Corpus ID: 8173826
The structure of the molybdenum site of xanthine oxidase in the complexes with alloxanthine, violapterin, and 6-pteridylaldehyde…
Expand
1984
1984
Metabolic studies of high doses of allopurinol in humans.
D. Nelson
,
G. Elion
Advances in Experimental Medicine and Biology
1984
Corpus ID: 35629288
In animals and in humans given high doses of allopurinol, the oxidation of allopurinol to oxipurinol is inhibited, resulting in a…
Expand
1984
1984
Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol?
D. Mertz
,
R. Eichhorn
Klinische Wochenschrift
1984
Corpus ID: 42189096
SummaryTwenty male hyperuricaemic patients with normal kidney function were studied and it was found that the serum…
Expand
1983
1983
Allopurinol metabolism in a patient with xanthine oxidase deficiency.
H. Yamanaka
,
K. Nishioka
,
T. Suzuki
,
K. Kohno
Annals of the Rheumatic Diseases
1983
Corpus ID: 45273351
A patient with complete deficiency of xanthine oxidase would not be expected to oxidase allopurinol to oxipurinol if allopurinol…
Expand
1983
1983
Oxipurinol therapy in allopurinol-allergic patients.
J. Earll
,
M. Saavedra
American Family Physician
1983
Corpus ID: 31165828
1981
1981
Bioavailability of allopurinol oral and rectal dosage forms.
S. L. Chang
,
W. Kramer
,
S. Feldman
,
R. Ballentine
,
L. Frankel
American journal of hospital pharmacy
1981
Corpus ID: 2167394
The bioavailability of allopurinol from orally administered tablets and rectally administered suppositories is reported. Two…
Expand
1974
1974
Ribonucleotides of allopurinol and oxipurinol in rat tissues and their significance in purine metabolism.
G. Elion
,
D. Nelson
Advances in Experimental Medicine and Biology
1974
Corpus ID: 31726206
In the early studies on the metabolism of allopurinol in animals and in man [1,2], it was not possible to find any allopurinol or…
Expand
1974
1974
Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). VI. Metabolism of D-DOPA in rat kidney.
H. Shindo
,
T. Maeda
Chemical and pharmaceutical bulletin
1974
Corpus ID: 12314098
The metabolism of the D-isomer of 3, 4-dihydroxyphenylalanine (D-DOPA) in rat kidney was investigated. After incubation of 9.05…
Expand
1970
1970
Effect of dietary purine restriction, allupurinol, and oxipurinol on urinary excretion of ultraviolet-absorbing compounds.
W. Kelley
,
J. Wyngaarden
Clinical Chemistry
1970
Corpus ID: 30516794
We demonstrate that purine restriction is associated with a decreased excretion of a number of uv-absorbing compounds—including…
Expand